Fifty 1 Labs, Inc. Stock

FITY

US2104931025

Biotechnology & Medical Research

Market Closed - OTC Markets 17:41:41 29/05/2026 +03			5-day change	1st Jan Change
0.000400 ^USD	+33.33%		+300.00%	-20.00%

08-26	Fifty 1 Labs, Inc. acquired Musculoskeletal Recovery Product Line of MSK Signal.	CI
08-10	Fifty 1 Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026	CI

Latest news: Fifty 1 Labs, Inc.

08-26	Fifty 1 Labs, Inc. acquired Musculoskeletal Recovery Product Line of MSK Signal.	CI
08-10	Fifty 1 Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026	CI
08-10	Fifty 1 Labs, Inc. Reports Earnings Results for the Full Year Ended June 30, 2025	CI
01-05	Fifty 1 Labs, Inc. Announces CEO Changes	CI
14/08/25	Fifty 1 Labs, Inc. Announces the Completion of the Largest and Most Comprehensive Study of Sickle Cell Disease	CI
10/07/25	Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling 50 1 Labs, Inc. Toward $50 Million Valuation	CI
30/04/25	Fifty 1 Labs, Inc. Appoints Michael Lawson as Chairman of the Board	CI
30/04/25	Fifty 1 Labs, Inc. Appoints Michael Lawson as Chief Executive Officer	CI
30/04/25	The Fifty 1 Labs Biosentry Division Will Develop State-Of-The-Art Biohazard Sensing Sensors Capable of Detecting Pathogens	CI
30/04/25	UAV Corp. Announces Strategic Partnership with 50 1 Labs, Inc	CI
08/04/25	Uav Corp And Genetic Networks Announce Strategic Collaboration	RE
20/03/25	Fifty 1 Labs, Inc. Appoints Gennaro D'Urso as CEO	CI
20/03/25	Fifty 1 Labs, Inc. Appoints Gennaro D'urso as Chairman	CI

More news

Press Releases: Fifty 1 Labs, Inc.

08-26	Fifty 1 Labs, Inc. Acquires MSK Signal Recovery Product Line to Accelerate Growth in the Peptide and Musculoskeletal Health Market	AQ
08-07	Fifty 1 Labs Outlines Planned U.S. Telehealth Peptide Services Platform	AQ
07-10	Fifty 1 Labs Announces Strategic Evolution into Peptide Biotechnology and Telehealth	AQ
04-15	Fifty 1 Labs, Inc. Accelerates Peptide Biotechnology Push into Musculoskeletal Health	AQ
04-14	Fifty 1 Labs, Inc. Eliminates 612 Million Shares from the Market	AQ

More press releases

Managers and Directors: Fifty 1 Labs, Inc.

Manager	Title	Age	Since
Pritpaul Singh Arora CEO	Chief Executive Officer	47	-
Brandon Spikes PSD	President	-	-
Alind Gupta CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Robert Clark BRD	Director/Board Member	49	30/04/2025
Brandon Spikes CHM	Chairman	-	12/07/2023
Curtis Young BRD	Director/Board Member	-	-

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FIFTY 1 LABS, INC.	+33.33%	+300.00%	-76.47%	-97.40%	118K
WUXI APPTEC CO., LTD.	-0.62%	-1.87%	+42.87%	+64.15%	63.77B
ARGENX SE	+0.35%	+3.20%	+14.40%	+81.76%	56.37B
LONZA GROUP AG	+0.53%	+1.96%	+16.24%	+103.35%	54.62B
IQVIA HOLDINGS INC.	-2.81%	-4.31%	+23.50%	+47.83%	44.06B
BEONE MEDICINES AG	-0.33%	-1.93%	+19.28%	+98.80%	42.11B
REVOLUTION MEDICINES, INC.	+0.55%	+2.31%	+225.14%	+866.21%	41B
GENMAB A/S	+3.27%	+47.96%	+112.84%	+96.58%	34.92B
CELLTRION, INC.	+1.22%	-1.44%	+14.57%	+46.95%	32.82B
INSMED INCORPORATED	+0.89%	+20.55%	-40.62%	+349.24%	24.7B
Average	+3.64%	+6.79%	+35.17%	+165.75%	39.43B
Weighted average by Cap.	+0.18%	+5.44%	+47.99%	+176.67%

See all sector performances

Fifty 1 Labs, Inc. is a biotechnology and life sciences company. The Company focuses on peptide products, peptide discovery, AI-enabled research, and clinical development. It also focuses on peptide science, musculoskeletal health, sports performance, injury recovery, rehabilitation, and evidence-driven wellness. It owns 51, LLC, its sports nutrition subsidiary offering a premium line of supplements including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies designed to enhance athletic performance, recovery, and overall health. It has acquired a musculoskeletal recovery product line. The product line includes five key product concepts designed to support the Company's peptide and musculoskeletal health markets. The portfolio includes natural health products focused on connective tissue recovery, inflammation support, post-surgical recovery nutrition, joint and cartilage support, and an investigational BPC-157-focused research platform.

Employees

Sector

Biotechnology & Medical Research

More about the company

Quotes

Date	Price	Change	Volume
30/10/26	$0.000100	-50.00%	315,000
29/10/26	$0.000200	-.--%	15,000
28/10/26	$0.000200	-.--%	804,000
27/10/26	$0.000200	-.--%	849,788
26/10/26	$0.000200	+100.00%	1,392,400

Real-time OTC Markets

More quotes

Stock Market
Stocks
FITY Stock

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	281K 252K 232K 210K 393K 26.73M 400K 2.77M 1.11M 14.06M 1.06M 1.03M 44.34M	P/E 2009	-0.05x	P/E 2010	-0.01x
Enterprise Value	12.55M 11.24M 10.34M 9.37M 17.52M 1.19B 17.84M 123M 49.51M 627M 47.12M 46.11M 1.98B	EV / Sales 2009	1.86x	EV / Sales 2010	2.41x
Free-Float	47.75%	Yield 2009 *	-	Yield 2010	-

1 day	+33.33%
1 week	+300.00%
Current month	+300.00%
1 month	+60.00%
Current year	-20.00%

1 week	0		0
1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0.05
5 years	0		0.2
10 years	0		0.23

	2009	2010
Net sales	5.41M 4.85M 4.46M 4.04M 7.55M 514M 7.69M 53.16M 21.34M 270M 20.31M 19.88M 852M	5.11M 4.57M 4.21M 3.81M 7.13M 485M 7.26M 50.17M 20.14M 255M 19.16M 18.76M 804M
Net income	-2.23M -2M -1.84M -1.67M -3.11M -212M -3.17M -21.92M -8.8M -111M -8.37M -8.2M -351M	-1.89M -1.7M -1.56M -1.41M -2.64M -180M -2.69M -18.61M -7.47M -94.61M -7.11M -6.96M -298M
Net Debt	9.96M 8.92M 8.2M 7.43M 13.89M 945M 14.15M 97.81M 39.26M 497M 37.36M 36.57M 1.57B	12.27M 10.99M 10.11M 9.16M 17.12M 1.17B 17.44M 121M 48.4M 613M 46.06M 45.08M 1.93B

Fifty 1 Labs, Inc. Stock

Stocks

FITY

US2104931025

Biotechnology & Medical Research

Valuation: Fifty 1 Labs, Inc.

Chart: Fifty 1 Labs, Inc.

Latest news: Fifty 1 Labs, Inc.

Press Releases: Fifty 1 Labs, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Fifty 1 Labs, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes